Published in Gene Therapy Weekly, March 6th, 2008
"The Pro72 variant has been associated with a slower induction of apoptosis and may influence the risk of cancer development. The role...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-03-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.